Sugi Predict

Sugi Predict / Compounds / SCHEMBL3129666

SCHEMBL3129666

SCHEMBL3129666

Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1c(=O)c2cnc([S+](C)[O-])nc2n(C)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNK2 Q07912 8/20 0.50
▸ MAP4K2 Q12851 8/20 0.50
▸ ABL1 P00519 6/20 0.50
▸ LCK P06239 3/20 0.50
▸ KIT P10721 3/20 0.50
▸ EPHB4 P54760 2/20 0.50
▸ BMX P51813 2/20 0.50
▸ TEK Q02763 2/20 0.50
▸ KDR P35968 2/20 0.50
▸ SRC P12931 2/20 0.50
▸ FES P07332 1/20 0.50
▸ RET P07949 1/20 0.50
▸ PDGFRB P09619 1/20 0.50
▸ FGFR1 P11362 1/20 0.50
▸ PDGFRA P16234 1/20 0.50
▸ FLT1 P17948 1/20 0.50
▸ FGFR3 P22607 1/20 0.50
▸ EPHA3 P29320 1/20 0.50
▸ KARS1 Q15046 1/20 0.50
▸ NTRK3 Q16288 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3139779 0.88 TNK2 (0.62) TNK2MAP4K2ABL1LCKKIT
SCHEMBL3135923 0.87 SYK (0.57) TNK2MAP4K2ABL1LCKKIT
SCHEMBL30338817 0.87 SYK (0.57) TNK2MAP4K2ABL1LCKKIT
SCHEMBL3143228 0.86 KDR (0.52) TNK2MAP4K2ABL1LCKKIT
SCHEMBL3134722 0.84 TNK2 (0.65) TNK2MAP4K2ABL1LCKBMX
SCHEMBL3144232 0.82 SYK (0.56) TNK2MAP4K2ABL1LCKKIT
SCHEMBL3132833 0.81 SYK (0.59) TNK2MAP4K2ABL1LCKBMX
SCHEMBL4785228 0.79 BTK (0.64) TNK2MAP4K2ABL1LCKKIT
SCHEMBL14213779 0.75 KDR (0.47) TNK2MAP4K2ABL1LCKKIT
SCHEMBL3825174 0.75 ABL1 (0.52) TNK2MAP4K2ABL1LCKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234400-A1 COMPOUNDS THAT MAINTAIN PLURIPOTENCY OF EMBRYONIC STEM CELLS IRM LLC (BM) 2010-09-16 — — US disclosed
US-7642255-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2010-01-05 — — US disclosed
US-20080221098-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-09-11 — — US disclosed
US-7371750-B2 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs IRM LLC (BM) 2008-05-13 — — US disclosed
US-20050222177-A1 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2005-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234400-A1 COMPOUNDS THAT MAINTAIN PLURIPOTENCY OF EMBRYONIC STEM CELLS LIFR, ALPG, BMI1 TNK2 3577/4885MAP4K2 2176/4885ABL1 1468/4885
US-20050222177-A1 Compounds and compositions as protein kinase inhibitors BMX, FES, FRK TNK2 203/4885MAP4K2 37/4885ABL1 66/4885
US-20080221098-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS BMX, FES, FRK TNK2 203/4885MAP4K2 37/4885ABL1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.